F.C. Moreira De Sousa, Dr
Research interests
Dr. Flávia Sousa is a Tenure-Track Assistant Professor at
the Department of Pharmaceutical Technology and Biopharmacy,
Groningen Research Institute of Pharmacy, University of Groningen,
Netherlands. She holds a background in pharmacy and earned her
Ph.D. in Biomedical Sciences from the University of Porto,
Portugal. Following her doctoral studies, Dr. Sousa pursued
postdoctoral research at Imperial College London, subsequently
securing a prestigious Marie Curie MINDED fellowship at the
Istituto Italiano di Tecnologia, Italy (2021-2022), and an
independent Women-in-Science (WINS) research fellowship from NCCR
Bio-inspired Materials at the Adolphe Merkle Institute, Fribourg,
Switzerland.
As a drug delivery scientist, Dr. Sousa is at the forefront of
developing innovative biological nanotherapies for brain cancer
treatment. Her pioneering research focuses on encapsulating
anti-angiogenic monoclonal antibodies to enhance their efficacy in
treating glioblastoma by normalizing tumor vasculature and the
tumor microenvironment. Currently, she is advancing the development
of a cancer nanovaccine for glioblastoma using state-of-the-art
nanotechnology.
Dr. Sousa's groundbreaking work has led to promising advancements
in brain cancer treatment, earning her numerous prestigious
international grants, including the Fulbright program, the
Marie-Sklodowska-Curie Fellowship, MIT Innovators Under 35, and the
Female Science Talents initiative. Over the past five years, she
has authored more than 40 publications, received 13 scientific
awards from various countries, garnered over 1800 citations, and
achieved an H-index of 24.